Titlebook: Liver Transplantation; Challenging Controve James F. Trotter,Gregory T. Everson Book 2009 Humana Press 2009 Surgery.Transplant Hepatology.c

熱情的我

量被毀壞

小母馬

violate

Pre- and Posttransplant Management of Hepatitis C,ansplanted with viremia, and recurrent hepatitis results in higher rates of graft and patient loss compared to other indications for transplantation. The most important factors that predict poor transplant outcome are advanced donor age and treatment of acute rejection. Therapy may be given prior to

增減字母法

解決

The Share 15 Rule, on the Model for End-Stage Liver Disease (MELD) score has allowed prioritization to be based on an objective measure of illness. In addition, after institution of the MELD system, policy makers were now able to measure differences among patients, institutions, and geographical areas that are much l

Expressly

Hepatocellular Carcinoma,ease in viral hepatitis over the last two decades has led to a dramatic increase in the incidence of HCC in the United States and other Western countries. In fact, the number of patients with HCC listed for transplantation will exceed the total number of available donors in the future. Preoperative

cajole

Liver Transplantation and the Hepatopulmonary Syndrome,patients without HPS. The only proven effective therapy for HPS is orthotopic liver transplantation (OLT), which should be considered when severe hypoxemia is present. The natural history of HPS without liver transplantation is dismal. While post-OLT mortality is increased in patients with HPS relat

元音

CHURL

Hepatitis B and Liver Transplantation,ge liver disease including hepatocellular carcinoma. Thus, liver transplantation has emerged as an important therapy for selected patients with HBV infection. The authors review the management of HBV before and after liver transplantation, which has become more complex with the advent of several new